PuSH - Publikationsserver des Helmholtz Zentrums München

Kramvis, A.* ; Chang, K.M.* ; Dandri, M.* ; Farci, P.* ; Glebe, D.* ; Hu, J.* ; Janssen, H.L.A.* ; Lau, D.T.Y.* ; Penicaud, C.* ; Pollicino, T.* ; Testoni, B.* ; Van Bömmel, F.* ; Andrisani, O.* ; Beumont-Mauviel, M.* ; Block, T.M.* ; Chan, H.L.Y.* ; Cloherty, G.A.* ; Delaney, W.E.* ; Geretti, A.M.* ; Gehring, A.* ; Jackson, K.* ; Lenz, O.* ; Maini, M.K.* ; Miller, V.* ; Protzer, U. ; Yang, J.C.* ; Yuen, M.F.* ; Zoulim, F.* ; Revill, P.A.*

A roadmap for serum biomarkers for hepatitis B virus: Current status and future outlook.

Nat. Rev. Gastroenterol. Hepatol. 19, 727-745 (2022)
Postprint Forschungsdaten DOI PMC
Open Access Green
Globally, 296 million people are infected with hepatitis B virus (HBV), and approximately one million people die annually from HBV-related causes, including liver cancer. Although there is a preventative vaccine and antiviral therapies suppressing HBV replication, there is no cure. Intensive efforts are under way to develop curative HBV therapies. Currently, only a few biomarkers are available for monitoring or predicting HBV disease progression and treatment response. As new therapies become available, new biomarkers to monitor viral and host responses are urgently needed. In October 2020, the International Coalition to Eliminate Hepatitis B Virus (ICE-HBV) held a virtual and interactive workshop on HBV biomarkers endorsed by the International HBV Meeting. Various stakeholders from academia, clinical practice and the pharmaceutical industry, with complementary expertise, presented and participated in panel discussions. The clinical utility of both classic and emerging viral and immunological serum biomarkers with respect to the course of infection, disease progression, and response to current and emerging treatments was appraised. The latest advances were discussed, and knowledge gaps in understanding and interpretation of HBV biomarkers were identified. This Roadmap summarizes the strengths, weaknesses, opportunities and challenges of HBV biomarkers.
Altmetric
Weitere Metriken?
[➜Einloggen]
Zusatzinfos bearbeiten [➜Einloggen]
Publikationstyp Artikel: Journalartikel
Dokumenttyp Review
Korrespondenzautor
ISSN (print) / ISBN 1759-5045
e-ISSN 1759-5053
Zeitschrift Nature Reviews - Gastroenterology & Hepatology
Quellenangaben Band: 19, Heft: 11, Seiten: 727-745 Artikelnummer: , Supplement: ,
Verlag Nature Publishing Group
Nichtpatentliteratur Publikationen
Begutachtungsstatus Peer reviewed
Institut(e) Institute of Virology (VIRO)